−0.05GBP
−3.19 MGBP
95.34 M
About SAREUM HOLDINGS PLC ORD GBP0.0125
Sector
Industry
CEO
Timothy John Mitchell
Website
Headquarters
Cambridge
Founded
2003
ISIN
GB00BMC3RJ87
FIGI
BBG000Q8ZXG5
Sareum Holdings Plc engages in the discovery and development of drug candidates for the treatment of cancers and autoimmune diseases. Its drug discovery pipeline includes Chk1, TYK2, and Aurora+FLT3 kinases. The company was founded by Timothy John Mitchell, David Hugh Williams, and John Charles Reader on August 1, 2003 and is headquartered in Cambridge, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SAR is 20.50 GBX — it has increased by 24.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SAREUM HOLDINGS PLC ORD GBP0.0125 stocks are traded under the ticker SAR.
SAREUM HOLDINGS PLC ORD GBP0.0125 is going to release the next earnings report on Oct 15, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SAREUM HOLDINGS PLC ORD GBP0.0125 has a max estimate of 1.75 GBX and a min estimate of 1.75 GBX.
Yes, you can track SAREUM HOLDINGS PLC ORD GBP0.0125 financials in yearly and quarterly reports right on TradingView.
Like other stocks, SAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAREUM HOLDINGS PLC ORD GBP0.0125 stock right from TradingView charts — choose your broker and connect to your account.